Posted inMedical Technology WuXi AppTec sells US medical device testing business to NAMSA January 17, 2025 WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based…
Posted inMedical Technology JPM25: GE HealthCare, UCSF launch research hub for cancer, neurodegenerative disease imaging January 15, 2025 SAN FRANCISCO—GE HealthCare is launching a new imaging research collaboration with the University of California, San Francisco, aimed at improving…
Posted inMedical Technology FDA elevates Philips cardiac telemetry recall over unflagged ECG alerts, following 2 deaths January 15, 2025 The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help…
Posted inMedical Technology JPM25: Dexcom predicts 2025 growth, with Stelo pushing portfolio updates January 14, 2025 SAN FRANCISCO—After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have…
Posted inMedical Technology JPM25: Medtronic begins rolling out adaptive brain stimulation for Parkinson’s after EU approval January 13, 2025 SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a…
Posted inMedical Technology JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project January 13, 2025 Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts…
Posted inMedical Technology JPM25: Guardant Health posts 31% sales gain as cancer blood tests expand January 13, 2025 SAN FRANCISCO—In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million…
Posted inMedical Technology Saluda Medical toasts $100M fundraising to pep up sales of its closed-loop neurostimulator January 10, 2025 The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its closed-loop implant aimed…
Posted inMedical Technology Insilico Medicine licenses 2nd AI-generated cancer drug candidate to Menarini’s Stemline in $550M deal January 9, 2025 Another new year, another half-billion-biobuck transaction between Insilico Medicine and the Italian drugmaker Menarini Group. Following a licensing agreement last…
Posted inMedical Technology Illumina rolls out single-cell & single-flow cell kits for low-volume labs January 9, 2025 Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making…